85 results on '"Scott, Kenneth L"'
Search Results
2. Supplementary Tables from HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer
3. Supplementary information from HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer
4. Tables S1-S6 from Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer
5. Data from Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer
6. Figures S1-S4 from Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer
7. Figures S1-S4 from Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer
8. Supplementary Figures from HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer
9. Data from Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer
10. Data from Identification of Variant-Specific Functions of PIK3CA by Rapid Phenotyping of Rare Mutations
11. Supplementary Tables S1-S5 from Identification of Variant-Specific Functions of PIK3CA by Rapid Phenotyping of Rare Mutations
12. Data from Identification of Variant-Specific Functions of PIK3CA by Rapid Phenotyping of Rare Mutations
13. Supplementary Tables S1-S5 from Identification of Variant-Specific Functions of PIK3CA by Rapid Phenotyping of Rare Mutations
14. Supplementary Figures S1-S2 from Identification of Variant-Specific Functions of PIK3CA by Rapid Phenotyping of Rare Mutations
15. Supplementary Figures S1-S2 from Identification of Variant-Specific Functions of PIK3CA by Rapid Phenotyping of Rare Mutations
16. In vivo functional characterization of EGFR variants identifies novel drivers of glioblastoma
17. A functional genomic approach to actionable gene fusions for precision oncology
18. POT1 Regulates Proliferation and Confers Sexual Dimorphism in Glioma
19. IMPAD1 and KDELR2 drive invasion and metastasis by enhancing Golgi-mediated secretion
20. Differential expression of MAGEA6 toggles autophagy to promote pancreatic cancer progression
21. Author response: Differential expression of MAGEA6 toggles autophagy to promote pancreatic cancer progression
22. PIK3CA variants selectively initiate brain hyperactivity during gliomagenesis
23. The RNA-binding protein AKAP8 suppresses tumor metastasis by antagonizing EMT-associated alternative splicing
24. PI4KIIIβ is a therapeutic target in chromosome 1q–amplified lung adenocarcinoma
25. High-Throughput Functional Validation of Progression Drivers in Lung Adenocarcinoma
26. Bacteria-to-Human Protein Networks Reveal Origins of Endogenous DNA Damage
27. High-Throughput Functional Validation of Progression Drivers in Lung Adenocarcinoma
28. Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies
29. Literature-based automated discovery of tumor suppressor p53 phosphorylation and inhibition by NEK2
30. RNA editing derived epitopes function as cancer antigens to elicit immune responses
31. TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins
32. In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer
33. The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network
34. Bacteria-to-human protein networks reveal origins of endogenous DNA damage
35. Cancer driver mutation prediction through Bayesian integration of multi-omic data
36. A-to-I RNA Editing Contributes to Proteomic Diversity in Cancer
37. A functional genomic screen in vivo identifies CEACAM5 as a clinically relevant driver of breast cancer metastasis
38. Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer
39. Systematic Functional Annotation of Somatic Mutations in Cancer
40. The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network
41. Alternative DNA Damage Checkpoint Pathways in Eukaryotes
42. Daam2 driven degradation of VHL promotes gliomagenesis
43. Author response: Daam2 driven degradation of VHL promotes gliomagenesis
44. HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer
45. Differential UBE2C and HOXA1 expression in melanocytic nevi and melanoma
46. Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer
47. A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations
48. Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers
49. Ba/F3 transformation assays
50. Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.